Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice.

Zhang L, Stadinski BD, Michels A, Kappler JW, Eisenbarth GS.

Diabetes Metab Res Rev. 2011 Nov;27(8):784-9. doi: 10.1002/dmrr.1252.

PMID:
22069260
2.

A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.

Chaturvedi P, Agrawal B, Zechel M, Lee-Chan E, Singh B.

J Immunol. 2000 Jun 15;164(12):6610-20.

3.
4.

The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.

Stratmann T, Apostolopoulos V, Mallet-Designe V, Corper AL, Scott CA, Wilson IA, Kang AS, Teyton L.

J Immunol. 2000 Sep 15;165(6):3214-25.

5.

A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.

Dunsavage MB, O'Leary CJ, Baumgart TD, Solvason N, Howard M, Lafferty K, Deshpande S, Reich EP.

J Autoimmun. 1999 Jun;12(4):233-42.

PMID:
10330294
6.

The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.

Carrasco-Marin E, Shimizu J, Kanagawa O, Unanue ER.

J Immunol. 1996 Jan 15;156(2):450-8.

PMID:
8543793
7.

HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.

Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC.

J Immunol. 2004 Mar 15;172(6):3955-62.

8.

A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.

Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L.

J Immunol. 1999 Jun 1;162(11):6630-40.

9.

Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.

Nabavieh A, Chou H, Volokhov I, Lee JE, Purdy LE, Elliott JF, Singh B, Madrenas J.

J Autoimmun. 1998 Feb;11(1):63-71.

PMID:
9480724
10.
13.

The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells.

Kanagawa O, Shimizu J, Unanue ER.

Int Immunol. 1997 Oct;9(10):1523-6.

PMID:
9352357
14.

Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.

Latek RR, Suri A, Petzold SJ, Nelson CA, Kanagawa O, Unanue ER, Fremont DH.

Immunity. 2000 Jun;12(6):699-710.

15.

I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.

Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.

J Immunol. 1999 Jul 15;163(2):743-50.

16.

Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.

Liu E, Moriyama H, Paronen J, Abiru N, Miao D, Yu L, Taylor RM, Eisenbarth GS.

J Autoimmun. 2003 Nov;21(3):213-9.

PMID:
14599846
17.

Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.

Elias D, Marcus H, Reshef T, Ablamunits V, Cohen IR.

Eur J Immunol. 1995 Oct;25(10):2851-7.

PMID:
7589082
18.

Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.

Scott GS, Fishman S, Khai Siew L, Margalit A, Chapman S, Chervonsky AV, Wen L, Gross G, Wong FS.

J Autoimmun. 2010 Dec;35(4):390-7. doi: 10.1016/j.jaut.2010.08.005. Epub 2010 Sep 20.

PMID:
20850948
19.

Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.

Elliott JF, Qin HY, Bhatti S, Smith DK, Singh RK, Dillon T, Lauzon J, Singh B.

Diabetes. 1994 Dec;43(12):1494-9.

PMID:
7525393
20.

Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.

Devendra D, Paronen J, Moriyama H, Miao D, Eisenbarth GS, Liu E.

J Autoimmun. 2004 Aug;23(1):17-26.

PMID:
15236749

Supplemental Content

Support Center